Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
NOT_YET_RECRUITING
NCT07152782
T-DXd With or Without Neratinib for HER2 Positive Breast Cancer With Brain Metastasis
202
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer With Brain Metastasis
HER2-positive Breast Cancer
NOT_YET_RECRUITING
NCT07151586
Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an Alterning Pattern to Patients With Metastatic or Locally Advanced Triple-negative Breast Cancer
260
Enrollment(s)
2
Study location(s)
INTERVENTIONAL (PHASE2)
Triple Negative Breast Neoplasms
Neoplasm Metastasis
HER 2 Low-expressing Breast Cancer
NOT_YET_RECRUITING
NCT07150208
T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain Metastasis
140
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer With Brain Metastasis
HER2-low Expressing Breast Cancer
RECRUITING
NCT05900206
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
370
Enrollment(s)
7
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer
COMPLETED
NCT04107727
Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)
273
Enrollment(s)
44
Study location(s)
INTERVENTIONAL (PHASE2)
Acute Myeloid Leukemia
ACTIVE_NOT_RECRUITING
NCT03568890
Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
510
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE4)
Left Atrial Appendage Closure
Thrombosis
Stroke
TIA
Bleeding
ACTIVE_NOT_RECRUITING
NCT05246514
A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC
72
Enrollment(s)
28
Study location(s)
INTERVENTIONAL (PHASE2)
HER2-mutant Non-Small Cell Lung Cancer
ACTIVE_NOT_RECRUITING
NCT05660135
Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia
4,000
Enrollment(s)
1
Study location(s)
OBSERVATIONAL (None)
Hypertension
Dyslipidemias
16
17
18
19
20